{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:41:49Z","timestamp":1791852109148,"version":"4.3.4"},"reference-count":73,"publisher":"American Association for Cancer Research (AACR)","issue":"14","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["15986"],"award-info":[{"award-number":["15986"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["Horizon ERC-2023-ADG-101141245"],"award-info":[{"award-number":["Horizon ERC-2023-ADG-101141245"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CGCATF-2025\/100002"],"award-info":[{"award-number":["CGCATF-2025\/100002"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["15986"],"award-info":[{"award-number":["15986"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["216135-2020"],"award-info":[{"award-number":["216135-2020"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"HORIZON EUROPE European Innovation Council","doi-asserted-by":"publisher","award":["865805"],"award-info":[{"award-number":["865805"]}],"id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["X-omics Initiative"],"award-info":[{"award-number":["X-omics Initiative"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["OCENW.M.22.001-16221"],"award-info":[{"award-number":["OCENW.M.22.001-16221"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["332727"],"award-info":[{"award-number":["332727"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["316060"],"award-info":[{"award-number":["316060"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2021074"],"award-info":[{"award-number":["2021074"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Arginine biosynthesis is frequently suppressed in cancer because of the loss of argininosuccinate synthase 1 (ASS1) expression, rendering cancer cells reliant on extracellular arginine. This feature has driven the development of systemic arginine-depleting strategies, which are clinically safe but offer limited clinical benefit. In this study, we demonstrated that under arginine scarcity, cancer cells with low ASS1 expression resort to aberrant mRNA translation, characterized by ribosomal frameshifts and amino acid misincorporations. Although aberrant proteins originated from most arginine codons, the predominant effect was observed at AGA. This codon preference was caused by a selective decrease in tRNAArg (UCU) levels following arginine deprivation, linked to methyltransferase-like 1 (METTL1)\u2013mediated tRNA modification. Proteomics and immunopeptidomics analyses validated that arginine shortage induced aberrant protein production at the endogenous level. T-cell receptor (TCR) T cells that specifically recognize these HLA-presented mistranslated peptides efficiently killed cancer cells after arginine deprivation. These results lay the foundation for improved cancer therapies by combining systemic arginine-depleting strategies with TCR-based targeting of nonclassical neoantigens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Aberrant protein production induced by arginine deprivation in ASS1-low cancers leads to production of neoantigens that represent promising targets for TCR-T cell therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-4773","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:01:47Z","timestamp":1778155307000},"page":"3480-3501","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9459-0741","authenticated-orcid":false,"given":"Remco","family":"Nagel","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-1942","authenticated-orcid":false,"given":"Adva","family":"Kochavi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-3406","authenticated-orcid":false,"given":"Karine","family":"Flem-Karlsen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j9c2840","id-type":"ROR","asserted-by":"publisher"}],"name":"Oslo University Hospital 2 Department of Cancer Immunology, , Radiumhospitalet, Oslo, Norway."},{"name":"3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3457-3771","authenticated-orcid":false,"given":"Mrittika","family":"Adhikary","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9182-1022","authenticated-orcid":false,"given":"Yali","family":"Gal-On","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3534-123X","authenticated-orcid":false,"given":"Maria G.","family":"Klaoudatou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-858X","authenticated-orcid":false,"given":"Julien","family":"Champagne","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7234-6694","authenticated-orcid":false,"given":"Lorenzo","family":"Valcanover","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6903-2180","authenticated-orcid":false,"given":"Heyilimu","family":"Palashati","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j9c2840","id-type":"ROR","asserted-by":"publisher"}],"name":"Oslo University Hospital 2 Department of Cancer Immunology, , Radiumhospitalet, Oslo, Norway."},{"name":"3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-2396","authenticated-orcid":false,"given":"Morten M.","family":"Nielsen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j9c2840","id-type":"ROR","asserted-by":"publisher"}],"name":"Oslo University Hospital 2 Department of Cancer Immunology, , Radiumhospitalet, Oslo, Norway."},{"name":"3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-1932","authenticated-orcid":false,"given":"Xiaodong","family":"Feng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9964-234X","authenticated-orcid":false,"given":"Pierre-Rene","family":"K\u00f6rner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-3256","authenticated-orcid":false,"given":"Lisanne","family":"Giebel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-0893","authenticated-orcid":false,"given":"Weiwen","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j9c2840","id-type":"ROR","asserted-by":"publisher"}],"name":"Oslo University Hospital 2 Department of Cancer Immunology, , Radiumhospitalet, Oslo, Norway."},{"name":"3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-8872","authenticated-orcid":false,"given":"Arno","family":"Velds","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 4 NKI Genomics Core Facility, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3552-6390","authenticated-orcid":false,"given":"Liesbeth","family":"Hoekman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 5 NKI Proteomics Facility, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9395-2347","authenticated-orcid":false,"given":"Onno B.","family":"Bleijerveld","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 5 NKI Proteomics Facility, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1037-6269","authenticated-orcid":false,"given":"Olaf","family":"van Tellingen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 6 Division of Pharmacology, , Amsterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-3100","authenticated-orcid":false,"given":"Johanna","family":"Olweus","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00j9c2840","id-type":"ROR","asserted-by":"publisher"}],"name":"Oslo University Hospital 2 Department of Cancer Immunology, , Radiumhospitalet, Oslo, Norway."},{"name":"3Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-2473","authenticated-orcid":false,"given":"Reuven","family":"Agami","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03xqtf034","id-type":"ROR","asserted-by":"publisher"}],"name":"The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute, , Amsterdam, the Netherlands."},{"name":"7Erasmus MC, Rotterdam University, Rotterdam, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026071503080908800_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"2026071503080908800_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat Cell Biol"},{"key":"2026071503080908800_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cell.2018.07.019","article-title":"Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures","volume":"174","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"2026071503080908800_bib4","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/ijc.25202","article-title":"Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer","volume":"126","author":"Delage","year":"2010","journal-title":"Int J Cancer"},{"key":"2026071503080908800_bib5","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/cddis.2012.197","article-title":"Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma","volume":"4","author":"Syed","year":"2013","journal-title":"Cell Death Dis"},{"key":"2026071503080908800_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature15529","article-title":"Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis","volume":"527","author":"Rabinovich","year":"2015","journal-title":"Nature"},{"key":"2026071503080908800_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/1471-2407-14-621","article-title":"Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy","volume":"14","author":"McAlpine","year":"2014","journal-title":"BMC Cancer"},{"key":"2026071503080908800_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ijc.24546","article-title":"Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer","volume":"125","author":"Nicholson","year":"2009","journal-title":"Int J Cancer"},{"key":"2026071503080908800_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ijc.30051","article-title":"Molecular basis and current strategies of therapeutic arginine depletion for cancer","volume":"139","author":"Fultang","year":"2016","journal-title":"Int J Cancer"},{"key":"2026071503080908800_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/cb900267j","article-title":"Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines","volume":"5","author":"Stone","year":"2010","journal-title":"ACS Chem Biol"},{"key":"2026071503080908800_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910510213","article-title":"In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini","volume":"51","author":"Takaku","year":"1992","journal-title":"Int J Cancer"},{"key":"2026071503080908800_bib12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10637-021-01149-8","article-title":"Safety, PK\/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors","volume":"39","author":"Cheng","year":"2021","journal-title":"Invest New Drugs"},{"key":"2026071503080908800_bib13","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1078-0432.CCR-14-2610","article-title":"Phase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumors","volume":"21","author":"Tomlinson","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026071503080908800_bib14","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","article-title":"Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc\/HIF-1alpha\/Sp4","volume":"8","author":"Tsai","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2026071503080908800_bib15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","article-title":"Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies","volume":"22","author":"Izzo","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026071503080908800_bib16","doi-asserted-by":"crossref","first-page":"58948","DOI":"10.18632\/oncotarget.19564","article-title":"PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration","volume":"8","author":"Brin","year":"2017","journal-title":"Oncotarget"},{"key":"2026071503080908800_bib17","doi-asserted-by":"crossref","first-page":"1943253","DOI":"10.1080\/2162402X.2021.1943253","article-title":"Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus pembrolizumab in advanced solid cancers","volume":"10","author":"Chang","year":"2021","journal-title":"Oncoimmunology"},{"key":"2026071503080908800_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/2326-6066.CIR-20-0317","article-title":"Arginase therapy combines effectively with immune checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth","volume":"9","author":"Badeaux","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"2026071503080908800_bib19","doi-asserted-by":"crossref","first-page":"109101","DOI":"10.1016\/j.celrep.2021.109101","article-title":"Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation","volume":"35","author":"Crump","year":"2021","journal-title":"Cell Rep"},{"key":"2026071503080908800_bib20","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1093\/nar\/gkae1110","article-title":"Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer","volume":"52","author":"Kochavi","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","article-title":"Anti-tumour immunity induces aberrant peptide presentation in melanoma","volume":"590","author":"Bartok","year":"2021","journal-title":"Nature"},{"key":"2026071503080908800_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","article-title":"Tryptophan depletion results in tryptophan-to-phenylalanine substitutants","volume":"603","author":"Pataskar","year":"2022","journal-title":"Nature"},{"key":"2026071503080908800_bib23","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.molcel.2021.09.002","article-title":"Oncogene-dependent sloppiness in mRNA translation","volume":"81","author":"Champagne","year":"2021","journal-title":"Mol Cell"},{"key":"2026071503080908800_bib24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.tig.2022.05.009","article-title":"Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting","volume":"38","author":"Champagne","year":"2022","journal-title":"Trends Genet"},{"key":"2026071503080908800_bib25","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.molcel.2024.04.012","article-title":"Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants","volume":"84","author":"Yang","year":"2024","journal-title":"Mol Cell"},{"key":"2026071503080908800_bib26","doi-asserted-by":"crossref","first-page":"e47886","DOI":"10.1371\/journal.pone.0047886","article-title":"Structural characterization of the enzymes composing the arginine deiminase pathway in Mycoplasma penetrans","volume":"7","author":"Gallego","year":"2012","journal-title":"PLoS One"},{"key":"2026071503080908800_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/1535-7163.MCT-18-0972","article-title":"Inhibition of the replication stress response is a synthetic vulnerability in SCLC that acts synergistically in combination with cisplatin","volume":"18","author":"Nagel","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2026071503080908800_bib28","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nprot.2012.086","article-title":"The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments","volume":"7","author":"Ingolia","year":"2012","journal-title":"Nat Protoc"},{"key":"2026071503080908800_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"CUTADAPT removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"key":"2026071503080908800_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2026071503080908800_bib31","doi-asserted-by":"crossref","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","article-title":"GENCODE 2021","volume":"49","author":"Frankish","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib32","doi-asserted-by":"crossref","first-page":"D184","DOI":"10.1093\/nar\/gkv1309","article-title":"GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes","volume":"44","author":"Chan","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib33","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"2026071503080908800_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16982","article-title":"Tumour-specific proline vulnerability uncovered by differential ribosome codon reading","volume":"530","author":"Loayza-Puch","year":"2016","journal-title":"Nature"},{"key":"2026071503080908800_bib35","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib36","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026071503080908800_bib38","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2024.12.004","article-title":"Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation","volume":"58","author":"Champagne","year":"2025","journal-title":"Immunity"},{"key":"2026071503080908800_bib40","doi-asserted-by":"crossref","first-page":"zcaf044","DOI":"10.1093\/narcan\/zcaf044","article-title":"Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models","volume":"7","author":"Kochavi","year":"2025","journal-title":"NAR Cancer"},{"key":"2026071503080908800_bib41","doi-asserted-by":"crossref","first-page":"W542","DOI":"10.1093\/nar\/gkz438","article-title":"tRNAviz: explore and visualize tRNA sequence features","volume":"47","author":"Lin","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026071503080908800_bib42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41590-025-02252-1","article-title":"TCR-engineered T cells targeting a shared \u03b2-catenin mutation eradicate solid tumors","volume":"26","author":"Eggeb\u00f8","year":"2025","journal-title":"Nat Immunol"},{"key":"2026071503080908800_bib43","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaf2288","article-title":"Targeting of cancer neoantigens with donor-derived T cell receptor repertoires","volume":"352","author":"Str\u00f8nen","year":"2016","journal-title":"Science"},{"key":"2026071503080908800_bib44","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s43018-023-00642-8","article-title":"A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo","volume":"4","author":"Giannakopoulou","year":"2023","journal-title":"Nat Cancer"},{"key":"2026071503080908800_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nm1360","article-title":"Design and use of conditional MHC class I ligands","volume":"12","author":"Toebes","year":"2006","journal-title":"Nat Med"},{"key":"2026071503080908800_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nmeth.1345","article-title":"Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers","volume":"6","author":"Hadrup","year":"2009","journal-title":"Nat Methods"},{"key":"2026071503080908800_bib47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nbt.2938","article-title":"Linking T-cell receptor sequence to functional phenotype at the single-cell level","volume":"32","author":"Han","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2026071503080908800_bib48","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1172\/JCI98819","article-title":"Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease","volume":"128","author":"Risnes","year":"2018","journal-title":"J Clin Invest"},{"key":"2026071503080908800_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41587-021-01089-x","article-title":"T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes","volume":"40","author":"Ali","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026071503080908800_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41467-017-00494-8","article-title":"Improved split fluorescent proteins for endogenous protein labeling","volume":"8","author":"Feng","year":"2017","journal-title":"Nat Commun"},{"key":"2026071503080908800_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molcel.2005.10.036","article-title":"Rapid tRNA decay can result from lack of nonessential modifications","volume":"21","author":"Alexandrov","year":"2006","journal-title":"Mol Cell"},{"key":"2026071503080908800_bib52","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.3390\/ijms19124080","article-title":"7-Methylguanosine modifications in transfer RNA (tRNA)","volume":"19","author":"Tomikawa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026071503080908800_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-022-05565-5","article-title":"Structures and mechanisms of tRNA methylation by METTL1-WDR4","volume":"613","author":"Ruiz-Arroyo","year":"2023","journal-title":"Nature"},{"key":"2026071503080908800_bib54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1017\/S1355838202024019","article-title":"Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA","volume":"8","author":"Alexandrov","year":"2002","journal-title":"RNA"},{"key":"2026071503080908800_bib55","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.emboj.7600648","article-title":"The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells","volume":"24","author":"Cartlidge","year":"2005","journal-title":"EMBO J"},{"key":"2026071503080908800_bib56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41586-022-05566-4","article-title":"Structural basis of regulated m7G tRNA modification by METTL1-WDR4","volume":"613","author":"Li","year":"2023","journal-title":"Nature"},{"key":"2026071503080908800_bib57","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/cancers13143541","article-title":"Arginine signaling and cancer metabolism","volume":"13","author":"Chen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026071503080908800_bib58","doi-asserted-by":"crossref","first-page":"102030","DOI":"10.1016\/j.jbc.2022.102030","article-title":"Prolonged deprivation of arginine or leucine induces PI3K\/Akt-dependent reactivation of mTORC1","volume":"298","author":"Buel","year":"2022","journal-title":"J Biol Chem"},{"key":"2026071503080908800_bib59","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"key":"2026071503080908800_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell Immunol"},{"key":"2026071503080908800_bib61","doi-asserted-by":"crossref","first-page":"113995","DOI":"10.1016\/j.celrep.2024.113995","article-title":"ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition","volume":"43","author":"Zou","year":"2024","journal-title":"Cell Rep"},{"key":"2026071503080908800_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res"},{"key":"2026071503080908800_bib63","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.4049\/jimmunol.177.9.6548","article-title":"Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes","volume":"177","author":"Johnson","year":"2006","journal-title":"J Immunol"},{"key":"2026071503080908800_bib64","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3389\/fimmu.2017.00864","article-title":"Reconstitution of T cell proliferation under arginine limitation: activated human T cells take up citrulline via L-type amino acid transporter 1 and use it to regenerate arginine after induction of argininosuccinate synthase expression","volume":"8","author":"Werner","year":"2017","journal-title":"Front Immunol"},{"key":"2026071503080908800_bib65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2026071503080908800_bib66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13073-015-0240-5","article-title":"TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression","volume":"7","author":"Scholtalbers","year":"2015","journal-title":"Genome Med"},{"key":"2026071503080908800_bib67","doi-asserted-by":"crossref","first-page":"658372","DOI":"10.3389\/fimmu.2021.658372","article-title":"ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery","volume":"12","author":"Finton","year":"2021","journal-title":"Front Immunol"},{"key":"2026071503080908800_bib68","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol Cell"},{"key":"2026071503080908800_bib69","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","article-title":"Modulated expression of specific tRNAs drives gene expression and cancer progression","volume":"165","author":"Goodarzi","year":"2016","journal-title":"Cell"},{"key":"2026071503080908800_bib70","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-22-1525","article-title":"Boosting antitumor immunity with an expanded neoepitope landscape","volume":"82","author":"Nagel","year":"2022","journal-title":"Cancer Res"},{"key":"2026071503080908800_bib71","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/2326-6066.CIR-17-0559","article-title":"Tumor immunity and survival as a function of alternative neopeptides in human cancer","volume":"6","author":"Rech","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"2026071503080908800_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/annonc\/mdx687","article-title":"Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma","volume":"29","author":"Ghorani","year":"2018","journal-title":"Ann Oncol"},{"key":"2026071503080908800_bib73","doi-asserted-by":"crossref","first-page":"eade9120","DOI":"10.1126\/sciadv.ade9120","article-title":"Arginine limitation drives a directed codon-dependent DNA sequence evolution response in colorectal cancer cells","volume":"9","author":"Hsu","year":"2023","journal-title":"Sci Adv"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4773\/3792812\/can-25-4773.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4773\/3800328\/can-25-4773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/14\/3480\/3810952\/can-25-4773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/14\/3480\/3810952\/can-25-4773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:08:27Z","timestamp":1784099307000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/14\/3480\/786561\/Arginine-Deprivation-of-ASS1-Deficient-Cancers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":73,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,5,7]]},"published-print":{"date-parts":[[2026,7,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-4773","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}